Olfactory ensheathing cells (OECs) are candidate cells for transplant-mediated repair of persistent demyelination in diseases such as multiple sclerosis. If this approach is to make the transition from laboratory to clinic, an important issue is the most suitable composition of the OEC transplant. Isolation of OECs involves concurrent isolation of other cell types, and speci®c selection techniques are required to produce puri®ed OECs. In this study we address whether the purity of the OEC transplant affects their ability to remyelinate. Surprisingly, we ®nd that a puri®ed preparation of OECs, selected on the basis of low-af®nity nerve growth factor receptor (p75) expression, results in less extensive remyelination than an unpuri®ed preparation following transplantation into areas of persistent demyelination in rodent CNS in the X-irradiation/ethidium bromide (X-EB) model. A distinctive feature of the unpuri®ed preparation both in vitro and following transplantation is the presence of meningeal cells. When meningeal cells are added to puri®ed OECs there is a signi®cant improvement in the extent of remyelination compared with the puri®ed OECs, although if the cells are present in too great an abundance this bene®cial effect is lost. These results highlight the important concept that the regenerative properties of OECs are profoundly in¯u-enced by the cells with which they are transplanted.
Introduction
Although the concept of transplanted-mediated remyelination of the CNS has been demonstrated many times using a variety of experimental models, its progression towards clinical implementation in diseases such as multiple sclerosis has been hampered by the limited availability of suitable cells (Zhang and Duncan, 2000; Halfpenny et al., 2002) . At present, it is not possible to obtain from human sources suf®ciently large numbers of progenitor cells committed to becoming oligodendrocytes (Blakemore and Franklin, 2000) , and the ef®cacy of Schwann cells is thought by many to be limited on account of their generally unfavourable interactions with astrocytes (Franklin and Blakemore, 1993; Wilby et al., 1999; Franklin 2002b) . The demonstration, ®rst in vitro (Devon and Doucette, 1992) and subsequently in vivo (Franklin et al., 1996; Imaizumi et al., 1998) , that olfactory ensheathing cells (OECs) can form myelin sheaths around axons of appropriate diameter has opened up the possibility of using these cells to remyelinate areas of persistent demyelination. This ®nding, together with the ability of OECs to promote axon regeneration and functional recovery following traumatic injury to the CNS (Li et al., 1997; Imaizumi et al., 2000; Ramon-Cueto et al., 2000; Lu et al., 2001; Pascual et al., 2002) , forms the basis of the current interest surrounding the therapeutic potential of these cells (Franklin and Barnett, 2000; Raisman, 2001; Franklin, 2002a ).
An unresolved and important issue is whether the ef®cacy of OEC transplantation is affected by the composition of the transplant. When OECs are prepared from olfactory tissue the resulting culture inevitably comprises many cell types. Is it necessary to generate pure OEC preparations by removing thè contaminants', which may potentially have disadvantageous effects (Brierley et al., 2001) , to obtain optimal results? In our own studies we have found that, following transplantation of a clonal cell line into an area of persistent demyelination, the overwhelming majority of transplanted cells adopt a myelinating phenotype. However, when we have transplanted primary preparations of OECs, alternative, non-myelinating cell morphologies are observed in proportions that vary from one preparation to another Smith et al., 2001 ). These cells have been variously described as being meningeal-like or astrocyte-like and bear some morphological similarity to the`A' cells described by Raisman and colleagues following transplantation of cell preparations containing OECs into sites of electrolytic white matter injury (Li et al., 1998) . In order to clarify the identity of the nonmyelinating cells seen following transplantation into demyelinating lesions and to investigate the bearing that they may have on the remyelinating potential of OECs, we transplanted different preparations of OECs: an unpuri®ed preparation, an OEC preparation puri®ed on the basis of low-af®nity nerve growth factor receptor (also known as p75) expression (Plant et al., 2002) , and two puri®ed OEC preparations to which we intentionally added olfactory bulb-derived meningeal cells. We found that puri®ed p75 + OECs have poor remyelinating capacity compared with unpuri®ed preparations of OECs, but that this difference can be overcome by adding a moderate proportion of cotransplanted meningeal cells. These results highlight an important concept: that the regenerative properties of OECs are profoundly in¯uenced by the cells with which they are transplanted and interact, and that the purity of the preparation transplanted is an issue that must be considered in accurately interpreting the regenerative ef®cacy of OECs.
Material and methods

OEC cultures
Olfactory bulbs were obtained from 7-day-old Fischer rat pups (Harlan, Blackthorn, UK). The outer layer of the rostral tip of the bulb was then dissected and dissociated to a cell suspension using a previously described protocol (Barnett et al., 1993) , and plated onto poly-L-lysine (PLL)-coated asks (T75, Nunc, Roskilde, Denmark) and initially grown in 10% FBS-DMEM (foetal bovine serum±Dulbecco's Modi®ed Eagle Medium). This preparation was used as the basis for both unpuri®ed and puri®ed OEC cultures.
To generate an unpuri®ed OEC preparation, the¯asks of con¯uent culture of olfactory bulb cells were only subjected to shaking for 3 h (275 r.p.m.), and the supernatant containinḡ oating cells (mainly microglia and oligodendrocyte progenitor cells) was discarded. The remaining cells were grown in 10% FBS-DMEM until harvested for transplantation.
In order to obtain a purer preparation of OECs, the cultures were then treated with cytosine arabinoside (10 ±5 M; Sigma, Poole, UK) to reduce the number of rapidly growing contaminants, such as endothelial cells, meningeal cells, astrocytes and progenitor cells. Cytosine arabinoside was applied for two 4-day periods from day 2, separated by 2 days in fresh 10% FBS-DMEM lacking cytosine arabinoside. Following the second cytosine arabinoside treatment and a subsequent 3 h shaking period (275 r.p.m.), the¯oating cells were removed and fresh culture medium was applied for 2± 18 h. Remaining cells were further puri®ed by brie¯y exposing the culture to trypsin (Sigma; 0.01% in Hanks medium) to dislodge the spindle or triangular shaped cells. Detached cells were harvested, washed twice in 10% FBS-DMEM and resuspended in Eagle's MEM-HEPES [Minimum Essential Medium±4-(2-hydroxyethyl) piperazine-1-ethane sulphonic acid]. The low-af®nity nerve growth factor receptor-expressing component of this population was isolated by immunopanning using an antibody against p75 (MA192 hybridoma supernatant; gift from Dr G. Plant). This procedure has been shown previously to produce a contaminant-free population of OECs (Plant et al., 2002) . To do this, Petri dishes were prepared by incubating with antimouse IgG (immunoglobulin G) antibody overnight (Dako, Ely, UK; 1 : 100, Tris 50 mM, pH 9.5) followed by anti-p75 antibody solution for 2 h at 4°C (1 : 6 solution of the hybridoma supernatant in Eagle's MEM-HEPES containing 2.5% FBS). The cell suspension was transferred into coated Petri dishes and incubated for 25 min at 4°C. Then the dishes were washed ®ve times with Hanks medium (Ca 2+ /Mg 2+ -free) to remove the non-adherent cells. The adherent p75 + cells were detached using a cell scraper (Grenier, Stonehouse, UK). These puri®ed cells were then washed twice in fresh medium and replated onto a ®bronectin-coated surface (10 mg/ ml; BD Biosciences, Bedford, MA, USA) in T25 culturē asks (Nunc) and then grown to subcon¯uency in fresh 10% FBS-DMEM supplemented with 2 mM forskolin and 20 ng/ml heregulin (R&D Systems Europe, Abingdon, UK). The cells were maintained under these conditions for at least 2 weeks before transplantation.
Meningeal cell culture
To grow olfactory bulb meningeal cells, the pia-arachnoid was carefully dissected from the olfactory bulbs of 7-day-old Fischer rat pups. The tissue was dissociated and cells were plated onto PLL-coated tissue culture and maintained in 10% FBS-DMEM for 7 days, by which time the cultures had formed a con¯uent monolayer. The¯asks were placed on a rotatory shaker overnight to remove the surface-dwelling cells, a procedure that was repeated 2 days later. In order to ensure that the meningeal cell preparation did not contain OECs, the p75-immunopanning procedure described above was conducted. However, on this occasion the non-adherent cells were retained and replated onto PLL-coated T25¯asks. The cells were grown for a further 5 days, and the remaining O4-and A2B5-expressing contaminant cells were removed by a complement-mediated cytolysis. Jackson Immunoresearch Labs, West Grove, PA, USA) were applied for a further 30 min at room temperature. All washing steps were carried out in 5% FBS-PBS (fetal bovine serum± phosphate-buffered saline). OECs were de®ned by strong p75 staining and either diffuse GFAP or weak ®bronectin immunoreactivity, whereas meningeal cells were identi®ed visualizing the enhanced ®bronectin labelling and no p75 labelling. For cell counts, in each sample at least three areas were assessed on multiple coverslips.
X-irradiation/ethidium bromide (X-EB) model of CNS demyelination and cell transplantation
In order to test the remyelinating capacity of the various cell preparations, suspensions of cells were transplanted into focal areas of persistent demyelination in the dorsal funiculus of the spinal cord of adult Fischer rats (~250 g, male). Persistent demyelination was induced using a combination of ethidium bromide injection (to induce demyelination) and local exposure of the spinal cord to X-irradiation (to prevent spontaneous remyelination). This lesion model is referred to as the X-EB lesion and has been used extensively to assess the remyelinating potential of transplanted cells (e.g. Franklin et al., 1996; Imaizumi et al., 1998; Smith et al., 2002) . Clear evidence that cells within the lesion are of transplant origin is provided by, inter alia, the presence of non-histocompatible cells in immunosuppressed hosts and their absence when immunosuppression is removed (Smith et al., 2002) . In brief, under anaesthesia induced and maintained using halothane, a dorsal laminectomy was performed on the T13 vertebra to expose the dorsal aspect of the spinal cord. With the aid of a three-way manipulator, the tip of a glass micropipette attached to a 10 ml Hamilton syringe was positioned within the dorsal funiculus and 1 ml of a 0.1% solution of ethidium bromide was injected to create a discrete area of demyelination. In order to suppress the remyelination by endogenous cells, the rats were restrained the day following lesioninduction by intramuscular injection of a mixture of uanisone and fentanyl (Hypnorm; Janssen Pharmaceutica, Beerse, Belgium; 0.30 ml/kg), and a 4 cm long section of the spinal cord including the lesion was exposed to 40 grays of Xirradiation using an orthovoltage radiotherapy machine (Pantak, East Haven, CT, USA). Following a further 48 h period, 1 ml of cell suspension that had been in culture for 3± 4 weeks was transplanted into the centre of the lesion in a similar fashion to the procedure used for lesion induction (see Table 2 for transplant composition). After each surgical procedure, a subcutaneous injection of caprofen (Zenecarp, Leyland, UK; 10 mg/kg) was administered to minimize discomfort, together with penicillin antibiosis (Duphapen; Fort Dodge, Southampton, UK; 0.5 ml/kg, intramuscularly). These procedures were performed under a Home Of®ce Licensing protocol.
Histology and immunohistochemistry
Animals were perfused with 4% glutaraldehyde via the descending aorta under deep pentobarbitone anaesthesia 4 weeks after transplantation. For resin embedding, the spinal cord was cut into a series of 1 mm thick coronal blocks that encompassed the entire lesion and were processed separately so as to maintain the craniocaudal sequence. Serial sections of 1 mm thickness were cut from each block and either stained with alkaline toluidine blue or processed for immunohistochemistry. Selected resin blocks were trimmed for ultrathin sectioning, stained with lead citrate/ uranyl acetate and viewed by electron microscopy. Toluidine blue-stained sections from each lesion-containing block were used to score remyelination.
For immunostaining, resin sections mounted on slides treated with Vectabond (Vector Laboratories, Peterborough, UK) were baked for 30 min at 80°C and then incubated in ascending concentrations of alcohol solutions (in 70, 90, 100 and 100% ethanol for 5 min each) using coplin jars. The slides were soaked in a sodium ethoxide±ethanol (1 : 1) solution for 30 min and then washed in ethanol to remove the super¯uous resin from sections. After peroxidase blocking with 3% H 2 O 2 in methanol, the sections were incubated ®rstly in 8% formic acid for 10 min and then in PBS containing 10% NGS (normal goat serum) and 0.1% Triton-X for a further 20 min. Anti-®bronectin antibody (1 : 500, rabbit; Dako; in 2% NGS, 0.1% Triton-X) was applied overnight at 4°C, followed by a biotin-labelled goat anti-rabbit secondary antibody (1 : 400, in PBS) for 1 h at room temperature. Anti-®bronectin antibody (1 : 500, rabbit; Dako; in 2% NGS, 0.1% Triton-X) was applied overnight at 4°C, followed by a biotin-labelled goat anti-rabbit secondary antibody (1 : 400; Sigma, UK; in PBS) for 1 h at room temperature. The staining was detected by applying the ABC complex (Vectastain; Vector Laboratories, Peterborough, UK) for a further 30 min before a colorimetric peroxidase reaction (for 5 min), using a diaminobenzidine substrate kit (Vector Laboratories, Peterborough, UK). All washing steps were carried out in PBS containing 0.1% Triton-X following the application of each reagent. Finally, the sections were air-dried, dehydrated and mounted using dibutyl phthalate.
Remyelination scoring
In resin sections, remyelinated axons can be readily distinguished from normally myelinated axons outside the lesion by their relatively thin myelin sheath. Within the lesion, remyelinated axons can be distinguished from demyelinated axons because the former possess myelin sheaths recognizable as a dark-staining rim around the axon. The myelin of OEC remyelination stains slightly darker than central myelin, and the proximity of the OEC nucleus frequently gives the myelinating OEC axon unit in transverse section a characteristic signet-ring appearance (Franklin et al., 1996) . Using these morphological criteria, it was possible to estimate the approximate percentages of demyelinated axons that had been remyelinated by OECs and of those that had remained demyelinated. Comparisons were made independently by the ®rst two authors using coded material, so that they were unaware of the cell preparation each scored section had received. When comparisons were made between transplant preparations, the mean remyelination scores and standard error of the mean for each group of animals were calculated and statistical comparisons were made using a non-parametric test (Kruskal±Wallis test, 5% con®dence interval) for comparisons between different transplant groups.
Results
Transplantation of puri®ed OEC preparations results in less extensive remyelination than transplantation of unpuri®ed preparations
In order to establish whether the degree of purity of OEC preparations affected their ability to remyelinate areas of CNS demyelination, preparations of either unpuri®ed OECs (preparation 1; Table 2) or OECs puri®ed by p75 immunopanning (preparation 2; Fig. 1 , Table 1 ), were transplanted into X-EB lesions in the dorsal funiculus of the spinal cord of adult syngeneic rats. The extent of remyelination was compared 3 weeks after transplantation. In lesions from animals in both groups, axons were identi®ed that had been remyelinated in a manner characteristic of transplanted OECs (Franklin et al., 1996; Imaizumi et al., 1998; Li et al., 1998) . Estimation of the extent of remyelination indicated that this was approximately 3-fold greater following transplantation of the unpuri®ed preparation compared with the puri®ed preparation (Fig. 2) .
The results of this comparison suggested that cells other than OECs present within the unpuri®ed preparation might be having a bene®cial effect on the remyelinating abilities of the transplanted OECs. Comparing the composition of the two preparations indicated that, whereas the puri®ed preparation consisted almost entirely of p75 + , weakly GFAP + OECs, the unpuri®ed preparation contained a signi®cant proportion of cells that strongly expressed ®bronectin, and these were provisionally identi®ed as meningeal cells (Fig. 1, Table 1 ). The identity of these cells was con®rmed by intentionally culturing similar ®bronectin-expressing cells from the meningeal layers dissected from the distal end of the olfactory bulb and obtaining cells of similar morphology and ®bronectin labelling.
Remyelination by OECs is increased when cotransplanted with small numbers of ®bronectin + meningeal cells
In order to test whether the presence of meningeal cells in the unpuri®ed olfactory bulb preparations contributed favourably to remyelination by transplanted OECs, we next added olfactory bulb-derived meningeal cells to the transplant suspension of puri®ed OECs to a ®nal composition of 30% meningeal cells and 70% OECs (preparation 3). The number of OECs in each transplant was the same as in the previous experiment, when puri®ed OECs alone were transplanted. Histological examination of the lesions 3 weeks after transplantation revealed more widespread remyelination than after transplantation of puri®ed OECs. Frequently, the remyelination extended to the lateral edges of the lesion and had a greater distribution along the lesion's longitudinal axis. An estimate of the proportion of axons that were remyelinated or that had remained demyelinated revealed a 3-fold increase in the degree of remyelination compared with that achieved following transplantation of puri®ed OECs alone. In order to verify that the increase in the extent of remyelination was not directly attributable to cells present within the meningeal component of the transplant suspension, we transplanted ®ve animals with the meningeal cell preparation only (preparation 5). In no case did we see any remyelination within the lesion (Figs 2 and 3) .
We next addressed whether the extent of remyelination could be increased further by increasing the proportion of meningeal cells. When a preparation that contained approximately equal proportions of meningeal cells and OECs (1 : 1) (preparation 4) was transplanted, while maintaining the same number of OECs as in previous transplants, the degree of remyelination was not signi®cantly greater than when the puri®ed OECs were transplanted alone. This indicated that the extent of remyelination achievable by transplanted OECs was not linearly related to the proportion of cotransplanted meningeal cells, and that the bene®cial effects of the meningeal presence was only manifested when OECs formed a substantial majority of the cells within the transplant (Figs 2  and 3 ).
Morphological arrangements adopted by meningeal cells cotransplanted with OECs
In lesions receiving puri®ed OECs (preparation 2) the predominant cell type, in addition to host axons and macrophages, was the remyelinating cell. These tended to be mainly in the centre of the lesion at the point of injection (Fig. 3) . The remyelinating cells in the lesions receiving the unpuri®ed preparation (preparation 1) were similar in appearance but more widely distributed. A key difference between the two preparations was that, in the lesions receiving the unpuri®ed preparation, cells were seen extending long processes around remyelinated axons, gathering them together in fascicles bounded in a perineurial-like arrangement (Fig. 4) . Such an arrangement has been described as one of two arrangements adopted by meningeal cells following glial cell transplantation, the alternative arrangement consisting of clumps or cords of tightly packed cells (Franklin et al., 1992) . Similar fascicles of OECmyelinated axons have been illustrated in previous OEC transplant studies, although the cells forming the fascicles were not speci®cally identi®ed (Li et al., 1998; Imaizumi et al., 2000; Smith et al., 2001) . If these cells were meningeal cells, one would predict that the frequency of fascicle formation would increase when increasing numbers of meningeal cells were added to the transplant. In the lesions receiving an OEC transplant with 20% meningeal cells, a small number of meningeal cells were indeed observed, and were even more abundant in the lesions transplanted with OECs and meningeal cells in a ratio of 1 : 1. Associated with the presence of meningeal cells was an increase in the abundance of large-diameter collagen within the extracellular Fig. 1 Antigenic pro®le of the unpuri®ed cultures of olfactory bulb cells (preparation 1) (A, C, E, F) and the immunopanned OECs (preparation 2) (B, D, G, H). In the unpuri®ed cultures a range of different morphologies are identi®able among the population of cells that express GFAP, including those that clearly resemble astrocytes (A). However, most of the cells are p75 + and have a morphology characteristic of OECs (C). Another prominent type of cell strongly expresses ®bronectin and these cells are identi®ed as meningeal cells (E). These cells do not express GFAP or p75 (large arrows in A, C, E and F). The p75 + OECs also express ®bronectin at low levels (small arrows in E and F). In the p75 immunopanned preparation, most cells express GFAP (B), p75 (D and H) and are weakly ®bronectin + (G). For quanti®cation of expression of different antigens see Table 1 . Scale bars: A±D, 50 mm; E±H, 25 mm. Dapi = 4¢,6-diamino-2-phenylindole dihydrochloride. space ( Fig. 5D and E) . However, in both cases the meningeal cells generally formed tightly packed clumps or cords of cells, and only rarely were perineurial-like arrangements of meningeal cells around bundles of OEC-myelinated axons observed. When meningeal cells alone were transplanted into X-EB lesions, they only formed clumps of cells and never adopted the fascicle-forming arrangements around axons seen when transplanted together with OECs (Figs 3 and 4) .
Selected sections were immunostained with ®bronectin antibodies to further characterize the arrangements of meningeal cells within the unpuri®ed transplants and when meningeal cells were cotransplanted with OECs. However, while ®bronectin remained largely adherent to the surface of The percentage of OECs (de®ned by p75 and diffuse GFAP expression) in each transplant was calculated from cells within the transplant suspension plated onto multiple coverslips immediately after transplantation (preparations 1 and 2). The proportions of p75 + /weak ®bronectin + OECs and strongly ®bronectin + and p75 ± meningeal cells (preparations 3 and 4) were calculated in preparations in which highly pure populations of OECs (from preparation 2) and meningeal cells (from preparation 5) were combined. Pure cultures of meningeal cells (~99% for ®bronectin + /p75 ± and <<0.5 for p75 + , preparation 5) were obtained by negative immunopanning for p75 and complement-mediated lysis for A2B5/O4. Remyelination is indicated as a percentage of all axons in the lesion remyelinated by OECs, and expressed as mean T standard error of the mean`n' values indicate the number of animals in each group. The numbers in brackets are the range and mean for the number of blocks in which remyelination was detected. M = meningeal cells; ±IP = negative immunopanning for p75; Hrg = heregulin; Fk = forskolin; OB = olfactory bulb. Data indicate the percentage of cells displaying strong (++), weak (+) and no GFAP immunoreactivity (±), which divides the populations into three major groups. The percentage cell proportions of the total population expressing various antigenic markers are listed. In the unpuri®ed population, the majority of OECs display p75 labelling combined with weak GFAP staining (~60%), and only a few cells bear stronger but diffuse GFAP immunoreactivity (<9%), besides small numbers of astrocyte-like cells (~3%). Nevertheless, a fraction of p75-labelled OECs may also express PSA-NCAM (polysialylated neural cell adhesion molecule) and O4 on their surface. The other major constituents of the population are p75 ± /GFAP ± meningeal-like cells displaying strong ®bronectin (~15%) staining and cells that express oligodendrocyte progenitor markers (A2B5/O4) (~10%). After a puri®cation procedure based on immunopanning (see Material and methods), mostly p75-immunoreactive OECs remain in the culture and only a very few ®bronectin + /P75 ± cells appear to contaminate the puri®ed OEC cultures. FN = ®bronectin; n.t. = not tested. Fig. 2 Histogram illustrating the extent of remyelination 3 weeks after transplantation of preparations 1±5 (Table 2) . Error bars represent standard error. *P < 0.05 (difference between preparations 3 and either 2 or 4).
meningeal cells in vitro, within the lesions there was strong staining, with ®bronectin associated with the surface of myelinating OECs, possibly localized to the basal lamina.
This distribution of ®bronectin is similar, although more intense, than that seen around myelinating Schwann cells in spinal roots (Fig. 6) . 
Discussion
Several proof-of-principle studies have been undertaken using a variety of CNS injury models that have established the pro-regenerative effects of transplanting OECs (Franklin and Barnett, 2000; Raisman, 2001) . In order to translate these studies into therapeutic approaches for treating clinical disease, a number of speci®c issues need to be resolved to render them practicable and to optimize success. Some of these have already begun to be addressed, such as (i) the availability of human OECs Kato et al., 2000) or OECs suitable for xenotransplantation (Imaizumi et al., 2000) , (ii) accessible sources of OECs (Lu et al., 2001) , (iii) the effectiveness of OEC transplantation in clinically relevant lesion models (Verdu et al., 2001) , and (iv) how long OEC transplantation is still ef®cacious after traumatic injury has occurred (Lu et al., 2002) . However, an issue that has received little attention thus far is the composition of the OEC transplant. If OECs are the cells responsible for mediating regeneration, is it bene®cial to transplant as pure a population of these cells as possible? In previous studies, OEC transplants of varying degrees of purity have been used, ranging from clonal cell lines of demonstrable purity to preparations in which no puri®cation steps were involved. In the present study we addressed how the purity of an OEC transplant affects the ability of these cells to remyelinate areas of primary demyelination, an issue of particular importance in considering the use of such an approach to repair areas of persistent demyelination in demyelinating diseases, such as multiple sclerosis. We ®nd that the remyelination achieved with an unpuri®ed OEC preparation is signi®cantly greater than that achieved with a purer OEC preparation, which has comparatively poor intrinsic remyelinating capacity. This result would appear to be at variance with the extent of remyelination that we have reported previously following transplantation of a clonal OEC line into the same lesion environment (Franklin et al., 1996) . However, this difference almost certainly re¯ects the greater proliferative propensity of the cell line compared with the primary cells. We also demonstrate that OECs selected on the basis of nerve growth factor receptor expression are unequivocally able to myelinate the large-diameter axons of the X-EB lesion, even though they appear unable to myelinate the very small-diameter axons generated by dorsal root ganglia preparations in vitro (Plant et al., 2002) . These results therefore strongly support the concept that the remyelinating capacity of OECs is dependent on axonal diameter rather than that their failure to myelinate in vitro re¯ects a general property of these cells. We also establish that olfactory bulb meningeal cells cotransplanted with OECs increase the ef®ciency of remyelination, and that these are likely to be the cells present within unpuri®ed preparations that optimize OEC-mediated remyelination. By what means might meningeal cells improve remyelination by transplanted OECs? Little is known about what directly effects OEC myelination. However, given the striking similarity between myelination by Schwann cells and by OECs, in terms of ultrastructural morphology Doucette, 1992, 1995; Franklin et al., 1996; Li et al., 1998) , biochemistry and transcriptional regulation (Smith et al., 2001) , studies on factors affecting Schwann cell myelination are likely to be informative. Meningeal cells, like ®broblasts, are mesenchyme-derived cells, and many studies have established the sensitivity of Schwann cells to mesenchymally derived factors (Obremski et al., 1993a, b) . A probable bene®cial effect of the presence of meningeal cells is their contribution to the extracellular matrix, which plays an important, although not essential, role in Schwann cell myelination (Eldridge et al., 1989; Podratz et al., 2001; Feltri et al., 2002) . In support of this notion, a denser and more abundant extracellular matrix was present following transplantation of preparations containing meningeal cells compared with the puri®ed OEC preparation. Moreover, the abundance of ®bronectin, a ligand for the b 1 integrin needed by Schwann cells to myelinate (Feltri et al., 2002) , also appeared to be increased around remyelinating OECs in the vicinity of meningeal cells. However, promoting the formation of myelin sheaths is unlikely to be the only bene®cial effect, since meningeal cell cotransplantation resulted in a greater number of myelinating OECs spread over a wider area, suggesting that their proliferation or migration might also be enhanced. A variety of growth factors are mitogenic for OECs (Yan et al., 2001; Alexander et al., 2002) , of which ®broblast growth factor 2 is known to be expressed by meningeal cells (Mercier and Hatton, 2000) , and this might have contributed to the increase in remyelination that we have documented.
We also demonstrate that the proportion of OECs and meningeal cells is important in remyelination, because when meningeal cells are transplanted in proportions to OECs of 50%±50% (preparation 4) rather than 30%±70% (preparation 3), their bene®cial effect on remyelination is not observed. This is somewhat similar to the observation that a high proportion of contaminating ®broblasts in Schwann cell preparations from adult human peripheral nerve severely impairs remyelination (Brierley et al., 2001) . However, we do not observe meningeal cells forming a dense swirling cellular mass with widespread deposition of extracellular matrix, or the consequent axonal injury reported in this earlier study, Fig. 5 Electron micrographs of sections from areas of demyelination after transplantation of different OEC preparations. After transplantation of a meningeal cell preparation (preparation 5), the ultrastructural features of these cells can be identi®ed. The nuclei are ovoid or elongate, with clumps of chromatin underneath the nuclear envelope (A). The cytoplasm of these cells contains large Golgi complexes, free ribosomes and small amounts of rough and smooth endoplasmic reticulum and lipid vacuoles (arrows, A). Junctional complexes occur between cells (arrow, B). Cells with a similar morphology are detected in transplants of OECs combined with meningeal cells (arrow, C), and their processes can be seen associated with remyelinating OECs (arrows, D). When meningeal cells are transplanted, the extracellular space around OEC-remyelinated axons is frequently full of collagen ®bres (E). When puri®ed OECs are transplanted, at the edge of their distribution OECs are often seen associating with axons but not forming compacted myelin sheaths (arrows, F). A relative lack of collagen ®brils within the extracellular space characterises both these areas and those in which OEC remyelination has occurred (inset, F). Scale bar: A, 2.5 mm; B, 0.5 mm; C, 2.0 mm; D, 0.5 mm; E, 1.0 mm; F, 3.3 mm; inset in F, 1.0 mm.
indicating that the failure of the higher meningeal cell component to promote remyelination cannot be explained solely on the basis of the meningeal cells over-running the lesion.
When meningeal cells were present as a component of unpuri®ed olfactory bulb cultures, they adopted two basic arrangements similar to those described previously for meningeal cells following glial cell transplantation into focal areas of demyelination. The meningeal cells either formed compacted clumps or cords of cells, or, more frequently, had a looser arrangement with long, ®ne processes that often encircled bundles of OEC-myelinated axons to create a structure resembling a perineurium-bound fascicle in the PNS. These arrangements have been described or illustrated in other studies in which OECs have been transplanted into models of either demyelination or traumatic injury (Li et al., 1998; Imaizumi et al., 2000; Smith et al., 2001) . In each case the transplant was not subjected to a substantial degree of OEC puri®cation and was likely to have contained meningeal cells from the surface of the olfactory bulb. The identity of these cells has remained equivocal. In the studies of Raisman and colleagues, in which unpuri®ed OEC preparations were transplanted into electrolytic lesions of spinal cord white matter, these cells are described as`A' cells to distinguish them from the myelin forming`S' cells (Li et al., 1998) . One interpretation of this nomenclature is that the S cells represent OECs while the A cells are olfactory bulb meningeal cells (which the authors describe as`®broblast- like' cells) also present within the transplant suspension (Li et al., 1998; Raisman, 2001 ). In the PNS, mesenchymederived cells are induced to form the perineurium by desert hedgehog (dhh) produced by Schwann cells (Parmantier et al., 1999) , and since OECs produce dhh (Smith et al., 2001) it is possible that a similar mechanism accounts for the formation of perineurial structures by meningeal cells. It was somewhat surprising, therefore, to ®nd that when OECs and meningeal cells are cultured separately and then combined in mixed OEC±meningeal cell preparations the meningeal cells generally adopted the compacted arrangements and that the perineurium formation was less frequently observed. The reason why meningeal cells cultured alone should behave differently from those continuously present within an OEC culture is not clear at present.
In this study we demonstrated that the intrinsic remyelinating capacity of OECs is limited but can be augmented by the presence of meningeal cells. It is also suggested that similar bene®cial effects may be exerted on OECs in their capacity to support axon regeneration following traumatic injury (Raisman, 2001) . Thus, in developing OEC transplantation as a therapeutic approach, there may be little advantage in obtaining pure OEC cultures. Rather, attention should be paid to how their regenerative potential can be optimized by the cells with which they are cotransplanted.
